| Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy AL Correia, JC Guimaraes, P Auf der Maur, D De Silva, MP Trefny, ... Nature 594 (7864), 566-571, 2021 | 237 | 2021 |
| Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment N Kirchhammer, MP Trefny, P Auf der Maur, H Läubli, A Zippelius Science translational medicine 14 (670), eabo3605, 2022 | 105 | 2022 |
| Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy MP Trefny, N Kirchhammer, P Auf der Maur, M Natoli, D Schmid, ... Nature Communications 14 (1), 86, 2023 | 42 | 2023 |
| Feed‐forward loops between metastatic cancer cells and their microenvironment—the stage of escalation Z Baumann, P Auf der Maur, M Bentires‐Alj EMBO Molecular Medicine 14 (6), e14283, 2022 | 36 | 2022 |
| The NFIB‐ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells F Zilli, P Marques Ramos, P Auf der Maur, C Jehanno, A Sethi, ... EMBO molecular medicine 13 (4), e13162, 2021 | 31 | 2021 |
| A high-throughput drug screen reveals means to differentiate triple-negative breast cancer M Vulin, C Jehanno, A Sethi, AL Correia, MMS Obradović, JP Couto, ... Oncogene 41 (39), 4459-4473, 2022 | 8 | 2022 |
| N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer P Auf der Maur, MP Trefny, Z Baumann, M Vulin, AL Correia, ... Cell Reports Medicine, 2023 | 7 | 2023 |
| Protein tyrosine phosphatase SHP2 controls interleukin-8 expression in breast cancer cells RJ Amante, P Auf der Maur, V Richina, A Sethi, V Iesmantavicius, ... Journal of Mammary Gland Biology and Neoplasia 27 (2), 145-153, 2022 | 6 | 2022 |
| Unraveling T-cell Exhaustion: Genetic Screening Meets In Vitro Modeling D Schmid, P Auf der Maur, MP Trefny, A Zippelius Cancer Research 83 (23), 3830-3832, 2023 | 1 | 2023 |
Alfred ZippeliusProfessor of Translational Oncology, Co-Head Medical OncologyVerified email at usb.ch